Cowen Prime Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $475K | Buy |
|
|||||
|
2023
Q1 | $542K | Sell |
|
|||||
|
2022
Q4 | $593K | Buy |
|
|||||
|
2022
Q3 | $329K | Hold |
|
|||||
|
2022
Q2 | $306K | Buy |
|
|||||
|
2022
Q1 | $289K | Sell |
|
|||||
|
2021
Q4 | $249K | Sell |
|
|||||
|
2021
Q3 | $792K | Hold |
|
|||||
|
2021
Q2 | $805K | Hold |
|
|||||
|
2021
Q1 | $938K | Hold |
|
|||||
|
2020
Q4 | $784K | Hold |
|
|||||
|
2020
Q3 | $732K | Buy |
|
|||||
|
2020
Q2 | $306K | Sell |
|
|||||
|
2020
Q1 | $730K | Hold |
|
|||||
|
2019
Q4 | $797K | Sell |
|
|||||
|
2019
Q3 | $565K | Hold |
|
|||||
|
2019
Q2 | $758K | Hold |
|
|||||
|
2019
Q1 | $1.29M | Sell |
|
|||||
|
2018
Q4 | $1.29M | Buy |
|
|||||
|
2018
Q3 | $1.43M | Sell |
|
|||||
|
2018
Q2 | $1.63M | Sell |
|
|||||
|
2018
Q1 | $1.2M | Sell |
|
|||||
|
2017
Q4 | $1.35M | Sell |
|
|||||
|
2017
Q3 | $2.57M | Sell |
|
|||||
|
2017
Q2 | $4.96M | Buy |
|
|||||
|
2017
Q1 | $4.79M | Buy |
|
|||||
|
2016
Q4 | $5.12M | Buy |
|
|||||
|
2016
Q3 | $6.47M | Buy |
|
|||||
|
2016
Q2 | $6.9M | Sell |
|
|||||
|
2016
Q1 | $7.36M | Buy |
|
|||||
|
2015
Q4 | $9M | Hold |
|
|||||
|
2015
Q3 | $7.74M | Sell |
|
|||||
|
2015
Q2 | $8.2M | Sell |
|
|||||
|
2015
Q1 | $8.75M | Sell |
|
|||||
|
2014
Q4 | $8.12M | Buy |
|
|||||
|
2014
Q3 | $7.44M | Buy |
|
|||||
|
2014
Q2 | $7.25M | Sell |
|
|||||
|
2014
Q1 | $7.33M | Buy |
|
|||||
|
2013
Q4 | $4.14M | Buy |
|
|||||
|
2013
Q3 | $3.85M | Buy |
|
|||||
|
2013
Q2 | $3.89M | Buy |
|